{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:17:09Z","timestamp":1784665029322,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["6698"],"award-info":[{"award-number":["6698"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["6698"],"award-info":[{"award-number":["6698"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["6698"],"award-info":[{"award-number":["6698"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["6698"],"award-info":[{"award-number":["6698"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02975-z","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T09:51:54Z","timestamp":1754128314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hesperetin increases membrane progesterone receptor expression in human myeloid leukemia cells and reduces ROS"],"prefix":"10.1007","volume":"42","author":[{"given":"Seyedeh Sindokht","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyas","family":"Esmailzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zangooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"issue":"1","key":"2975_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00411-013-0507-4","volume":"53","author":"T Radivoyevitch","year":"2014","unstructured":"Radivoyevitch T, Jankovic GM, Tiu RV, Saunthararajah Y, Jackson RC, Hlatky LR, et al. Sex differences in the incidence of chronic myeloid leukemia. Radiat Environ Biophys. 2014;53(1):55\u201363. https:\/\/doi.org\/10.1007\/s00411-013-0507-4.","journal-title":"Radiat Environ Biophys"},{"key":"2975_CR2","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.blre.2021.100825","volume":"49","author":"AEG Osman","year":"2021","unstructured":"Osman AEG, Deininger MW. Chronic myeloid leukemia: modern therapies, current challenges and future directions. Blood Rev. 2021;49:100825. https:\/\/doi.org\/10.1016\/j.blre.2021.100825.","journal-title":"Blood Rev"},{"issue":"1","key":"2975_CR3","doi-asserted-by":"publisher","first-page":"e21077","DOI":"10.7759\/cureus.21077","volume":"14","author":"H Arzoun","year":"2022","unstructured":"Arzoun H, Srinivasan M, Thangaraj SR, Thomas SS, Mohammed L. The progression of chronic myeloid leukemia to myeloid sarcoma: a systematic review. Cureus. 2022;14(1):e21077. https:\/\/doi.org\/10.7759\/cureus.21077.","journal-title":"Cureus"},{"issue":"7","key":"2975_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H Sies","year":"2022","unstructured":"Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23(7):499\u2013515. https:\/\/doi.org\/10.1038\/s41580-022-00456-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2975_CR5","doi-asserted-by":"publisher","first-page":"117727191875539","DOI":"10.1177\/1177271918755391","volume":"13","author":"S Kumari","year":"2018","unstructured":"Kumari S, Badana AK, G MM, G S, Malla R. Reactive oxygen species: a key constituent in cancer survival. Biomark Insights. 2018;13:1177271918755391. https:\/\/doi.org\/10.1177\/1177271918755391.","journal-title":"Biomark Insights"},{"key":"2975_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2017.01.004","volume":"104","author":"S Galadari","year":"2017","unstructured":"Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144\u201364. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.004.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2975_CR7","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41598-018-20179-6","volume":"8","author":"YA Larasati","year":"2018","unstructured":"Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato J-y. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep. 2018;8(1):2039. https:\/\/doi.org\/10.1038\/s41598-018-20179-6.","journal-title":"Sci Rep"},{"issue":"1","key":"2975_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130\u201362. https:\/\/doi.org\/10.1210\/er.2012-1043.","journal-title":"Endocr Rev"},{"issue":"9","key":"2975_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.steroids.2011.01.008","volume":"76","author":"Y Pang","year":"2011","unstructured":"Pang Y, Thomas P. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor. Steroids. 2011;76(9):921\u20138. https:\/\/doi.org\/10.1016\/j.steroids.2011.01.008.","journal-title":"Steroids"},{"issue":"2","key":"2975_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.steroids.2006.10.006","volume":"72","author":"GE Dressing","year":"2007","unstructured":"Dressing GE, Thomas P. Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer. Steroids. 2007;72(2):111\u20136. https:\/\/doi.org\/10.1016\/j.steroids.2006.10.006.","journal-title":"Steroids"},{"issue":"8","key":"2975_CR11","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/ijc.25207","volume":"127","author":"W Yue","year":"2010","unstructured":"Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, et al. Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms. Int J Cancer. 2010;127(8):1748\u201357. https:\/\/doi.org\/10.1002\/ijc.25207.","journal-title":"Int J Cancer"},{"issue":"4","key":"2975_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12672-010-0023-9","volume":"1","author":"NJ Charles","year":"2010","unstructured":"Charles NJ, Thomas P, Lange CA. Expression of membrane progesterone receptors (mPR\/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events. Horm Cancer. 2010;1(4):167\u201376. https:\/\/doi.org\/10.1007\/s12672-010-0023-9.","journal-title":"Horm Cancer"},{"issue":"4","key":"2975_CR13","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/fft2.287","volume":"4","author":"H Xue","year":"2023","unstructured":"Xue H, Xu M, Gong D, Zhang G. Mechanism of flavonoids inhibiting xanthine oxidase and alleviating hyperuricemia from structure\u2013activity relationship and animal experiments: a review. Food Frontiers. 2023;4(4):1643\u201365. https:\/\/doi.org\/10.1002\/fft2.287.","journal-title":"Food Frontiers"},{"issue":"2","key":"2975_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s10753-014-9995-x","volume":"38","author":"D Ribeiro","year":"2015","unstructured":"Ribeiro D, Freitas M, Tom\u00e9 SM, Silva AM, Laufer S, Lima JL, et al. Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine\/chemokine production in human whole blood. Inflammation. 2015;38(2):858\u201370. https:\/\/doi.org\/10.1007\/s10753-014-9995-x.","journal-title":"Inflammation"},{"key":"2975_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/342973","author":"RP Constantin","year":"2013","unstructured":"Constantin RP, Nascimento GS, Constantin RP, Salgueiro CL, Bracht A, Ishii-Iwamoto EL, Yamamoto NS, Constantin J. Citrus flavanones affect hepatic fatty acid oxidation in rats by acting as prooxidant agents. Biomed Res Int. 2013. https:\/\/doi.org\/10.1155\/2013\/342973.","journal-title":"Biomed Res Int"},{"issue":"8","key":"2975_CR16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jcp.24818","volume":"230","author":"S Palit","year":"2015","unstructured":"Palit S, Kar S, Sharma G, Das PK. Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1\/JNK pathway. J Cell Physiol. 2015;230(8):1729\u201339. https:\/\/doi.org\/10.1002\/jcp.24818.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2975_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/ejcn.2010.6","volume":"64","author":"KS Krogholm","year":"2010","unstructured":"Krogholm KS, Bredsdorff L, Knuthsen P, Haraldsd\u00f3ttir J, Rasmussen SE. Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. Eur J Clin Nutr. 2010;64(4):432\u20135. https:\/\/doi.org\/10.1038\/ejcn.2010.6.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2975_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/01635580701419030","volume":"59","author":"EJ Choi","year":"2007","unstructured":"Choi EJ. Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr Cancer. 2007;59(1):115\u20139. https:\/\/doi.org\/10.1080\/01635580701419030.","journal-title":"Nutr Cancer"},{"issue":"3","key":"2975_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s42000-021-00291-5","volume":"20","author":"M Rafiee","year":"2021","unstructured":"Rafiee M, Rezaei A, Alipour R, Sereshki N, Motamedi N, Naseri M. Progesterone-induced blocking factor (PIBF) influences the expression of membrane progesterone receptors (mPRs) on peripheral CD4(+) T lymphocyte cells in normal fertile females. Hormones (Athens). 2021;20(3):507\u201314. https:\/\/doi.org\/10.1007\/s42000-021-00291-5.","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2975_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/17446651.2023.2166487","volume":"18","author":"JH Check","year":"2023","unstructured":"Check JH, Check DL. The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Rev Endocrinol Metab. 2023;18(1):5\u201318. https:\/\/doi.org\/10.1080\/17446651.2023.2166487.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"5","key":"2975_CR21","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1007\/s13277-015-4118-3","volume":"37","author":"A Adan","year":"2016","unstructured":"Adan A, Baran Y. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Tumour Biol: J Int Soc Oncodev Biol Med. 2016;37(5):5781\u201395. https:\/\/doi.org\/10.1007\/s13277-015-4118-3.","journal-title":"Tumour Biol: J Int Soc Oncodev Biol Med"},{"key":"2975_CR22","doi-asserted-by":"publisher","DOI":"10.3791\/3357","author":"D Wu","year":"2011","unstructured":"Wu D, Yotnda P. Production and detection of reactive oxygen species (ROS) in cancers. J Vis Exp. 2011. https:\/\/doi.org\/10.3791\/3357.","journal-title":"J Vis Exp"},{"issue":"1","key":"2975_CR23","doi-asserted-by":"publisher","first-page":"e2019025","DOI":"10.4084\/mjhid.2019.025","volume":"11","author":"E Abruzzese","year":"2019","unstructured":"Abruzzese E, Bosi A, Breccia M, D\u2019Adda M, Di Renzo N, Liberati AM, et al. Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: the simplicity italian population. Mediterr J Hematol Infect Dis. 2019;11(1):e2019025. https:\/\/doi.org\/10.4084\/mjhid.2019.025.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"17","key":"2975_CR24","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2174\/1871520622666220426104631","volume":"22","author":"A Akotiah","year":"2022","unstructured":"Akotiah A, Walker D, Boddie S, Campbell RB. Drug targeting and therapeutic management of chronic myeloid leukemia: conventional and nanotherapeutic drug options. Anticancer Agents Med Chem. 2022;22(17):2933\u201341. https:\/\/doi.org\/10.2174\/1871520622666220426104631.","journal-title":"Anticancer Agents Med Chem"},{"issue":"14","key":"2975_CR25","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2169\/internalmedicine.6620-20","volume":"60","author":"M Chiwata","year":"2021","unstructured":"Chiwata M, Itonaga H, Sato S, Hashimoto M, Fujioka M, Kasai S, et al. Efficacy and cardiovascular adverse events of long-term treatment with tyrosine kinase inhibitors for chronic myeloid leukemia: a report from the Nagasaki CML study group. Intern Med. 2021;60(14):2207\u201316. https:\/\/doi.org\/10.2169\/internalmedicine.6620-20.","journal-title":"Intern Med"},{"key":"2975_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174354","author":"O Kronick","year":"2023","unstructured":"Kronick O, Chen X, Mehra N, Varmeziar A, Fisher R, Kartchner D, et al. Hematological adverse events with tyrosine kinase inhibitors for chronic myeloid leukemia: a systematic review with meta-analysis. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15174354.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2975_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.amjsurg.2010.08.018","volume":"201","author":"B Zarebczan","year":"2011","unstructured":"Zarebczan B, Pinchot SN, Kunnimalaiyaan M, Chen H. Hesperetin, a potential therapy for carcinoid cancer. Am J Surg. 2011;201(3):329\u201332. https:\/\/doi.org\/10.1016\/j.amjsurg.2010.08.018.","journal-title":"Am J Surg"},{"issue":"12","key":"2975_CR28","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1016\/j.sjbs.2021.07.046","volume":"28","author":"KM Yap","year":"2021","unstructured":"Yap KM, Sekar M, Wu YS, Gan SH, Rani N, Seow LJ, et al. Hesperidin and its aglycone hesperetin in breast cancer therapy: a review of recent developments and future prospects. Saudi J Biol Sci. 2021;28(12):6730\u201347. https:\/\/doi.org\/10.1016\/j.sjbs.2021.07.046.","journal-title":"Saudi J Biol Sci"},{"key":"2975_CR29","doi-asserted-by":"publisher","first-page":"108779","DOI":"10.1016\/j.biopha.2019.108779","volume":"113","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu S, Dong W, Qu X, Huang C, Yan T, et al. Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma. Biomed Pharm. 2019;113:108779. https:\/\/doi.org\/10.1016\/j.biopha.2019.108779.","journal-title":"Biomed Pharm"},{"issue":"3","key":"2975_CR30","first-page":"181","volume":"14","author":"AN Artanti","year":"2023","unstructured":"Artanti AN, Jenie RI, Rumiyati R, Meiyanto E. Cytotoxic activity and senescence modulatory effect of hesperetin on triple-negative breast cancer cells and kidney cells co-treatment with cisplatin. Indones J Cancer Chemoprev. 2023;14(3):181\u20138.","journal-title":"Indones J Cancer Chemoprev"},{"key":"2975_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27206806","author":"T Carevi\u0107","year":"2022","unstructured":"Carevi\u0107 T, Kosti\u0107 M, Nikoli\u0107 B, Stojkovi\u0107 D, Sokovi\u0107 M, Ivanov M. Hesperetin-between the ability to diminish mono- and polymicrobial biofilms and toxicity. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27206806.","journal-title":"Molecules"},{"issue":"43","key":"2975_CR32","doi-asserted-by":"publisher","first-page":"24434","DOI":"10.1039\/C8RA00956B","volume":"8","author":"D Wu","year":"2018","unstructured":"Wu D, Li J, Hu X, Ma J, Dong W. Hesperetin inhibits Eca-109 cell proliferation and invasion by suppressing the PI3K\/AKT signaling pathway and synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal cancer in vitro and in vivo. RSC Adv. 2018;8(43):24434\u201343. https:\/\/doi.org\/10.1039\/C8RA00956B.","journal-title":"RSC Adv"},{"issue":"3","key":"2975_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/01635581.2019.1638424","volume":"72","author":"Q Li","year":"2020","unstructured":"Li Q, Miao Z, Wang R, Yang J, Zhang D. Hesperetin induces apoptosis in human glioblastoma cells via p38 MAPK activation. Nutr Cancer. 2020;72(3):538\u201345. https:\/\/doi.org\/10.1080\/01635581.2019.1638424.","journal-title":"Nutr Cancer"},{"issue":"8","key":"2975_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12272-019-01174-5","volume":"42","author":"SH Jo","year":"2019","unstructured":"Jo SH, Kim ME, Cho JH, Lee Y, Lee J, Park Y-D, et al. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways. Arch Pharmacal Res. 2019;42(8):695\u2013703. https:\/\/doi.org\/10.1007\/s12272-019-01174-5.","journal-title":"Arch Pharmacal Res"},{"key":"2975_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102383","author":"C Russo","year":"2022","unstructured":"Russo C, Maugeri A, De Luca L, Gitto R, Lombardo GE, Musumeci L, et al. The SIRT2 pathway is involved in the antiproliferative effect of flavanones in human leukemia monocytic THP-1 cells. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10102383.","journal-title":"Biomedicines"},{"issue":"2","key":"2975_CR36","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cimb45020102","volume":"45","author":"CY Lin","year":"2023","unstructured":"Lin CY, Chen YH, Huang YC. Hesperetin induces autophagy and delayed apoptosis by modulating the AMPK\/Akt\/mTOR pathway in human leukemia cells in vitro. Curr Issues Mol Biol. 2023;45(2):1587\u2013600. https:\/\/doi.org\/10.3390\/cimb45020102.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"2975_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.61186\/jbums.30.1.99","volume":"30","author":"M Zangooei","year":"2023","unstructured":"Zangooei M, Bagheri V. Simultaneous effect of progesterone and berberine on the level of reactive oxygen species in K562 cell. J Birjand Univ Med Sci. 2023;30(1):99\u2013106. https:\/\/doi.org\/10.61186\/jbums.30.1.99.","journal-title":"J Birjand Univ Med Sci"},{"key":"2975_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cancergen.2024.10.006","volume":"288","author":"V Bagheri","year":"2024","unstructured":"Bagheri V, Rezaei F, Alipour R, Sereshki N, Ahmadipanah V, Rafiee M. Progesterone decreases viability and up regulates membrane progesterone receptors expression on the human chronic myeloid leukemia cell line. Cancer Genet. 2024;288:114\u20137. https:\/\/doi.org\/10.1016\/j.cancergen.2024.10.006.","journal-title":"Cancer Genet"},{"issue":"3","key":"2975_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF01855641","volume":"183","author":"K Paveli\u0107","year":"1983","unstructured":"Paveli\u0107 K, Petru\u0161i\u0107 L, Osmak M, \u010culo F. In vivo and in vitro effect of progesterone on the growth of some mouse and human tumours. Res Exp Med. 1983;183(3):183\u201391. https:\/\/doi.org\/10.1007\/BF01855641.","journal-title":"Res Exp Med"},{"key":"2975_CR40","doi-asserted-by":"publisher","first-page":"101991","DOI":"10.1016\/j.genrep.2024.101991","volume":"36","author":"N Fallahi","year":"2024","unstructured":"Fallahi N, Rafiee M, Azaryan E, Wilkinson D, Bagheri V. Inhibitory effects of progesterone on the human acute lymphoblastic leukemia cell line. Gene Rep. 2024;36:101991. https:\/\/doi.org\/10.1016\/j.genrep.2024.101991.","journal-title":"Gene Rep"},{"key":"2975_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10050642","author":"S Arfin","year":"2021","unstructured":"Arfin S, Jha NK, Jha SK, Kesari KK, Ruokolainen J, Roychoudhury S, et al. Oxidative stress in cancer cell metabolism. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10050642.","journal-title":"Antioxidants"},{"issue":"1","key":"2975_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/med.21734","volume":"41","author":"J Zhang","year":"2021","unstructured":"Zhang J, Duan D, Song ZL, Liu T, Hou Y, Fang J. Small molecules regulating reactive oxygen species homeostasis for cancer therapy. Med Res Rev. 2021;41(1):342\u201394. https:\/\/doi.org\/10.1002\/med.21734.","journal-title":"Med Res Rev"},{"key":"2975_CR43","doi-asserted-by":"publisher","first-page":"112442","DOI":"10.1016\/j.biopha.2021.112442","volume":"146","author":"H Slika","year":"2022","unstructured":"Slika H, Mansour H, Wehbe N, Nasser SA, Iratni R, Nasrallah G, et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442. https:\/\/doi.org\/10.1016\/j.biopha.2021.112442.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2975_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.fct.2011.11.038","volume":"50","author":"G Sivagami","year":"2012","unstructured":"Sivagami G, Vinothkumar R, Preethy CP, Riyasdeen A, Akbarsha MA, Menon VP, et al. Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line \u2013 a comparative study. Food Chem Toxicol. 2012;50(3):660\u201371. https:\/\/doi.org\/10.1016\/j.fct.2011.11.038.","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"2975_CR45","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s10620-015-3696-7","volume":"60","author":"J Zhang","year":"2015","unstructured":"Zhang J, Wu D, Vikash SJ, Wang J, Yi J, et al. Hesperetin induces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species. Digestive Dis Sci. 2015;60(10):2985\u201395. https:\/\/doi.org\/10.1007\/s10620-015-3696-7.","journal-title":"Digestive Dis Sci"},{"key":"2975_CR46","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.2147\/ijn.s108633","volume":"11","author":"H Li","year":"2016","unstructured":"Li H, Tian J, Wu A, Wang J, Ge C, Sun Z. Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma. Int J Nanomed. 2016;11:4373\u201380. https:\/\/doi.org\/10.2147\/ijn.s108633.","journal-title":"Int J Nanomed"},{"issue":"22","key":"2975_CR47","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1182\/blood-2011-01-326025","volume":"117","author":"PS Hole","year":"2011","unstructured":"Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias? Blood. 2011;117(22):5816\u201326. https:\/\/doi.org\/10.1182\/blood-2011-01-326025.","journal-title":"Blood"},{"issue":"1","key":"2975_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1021\/jf2040675","volume":"60","author":"H-L Yang","year":"2012","unstructured":"Yang H-L, Chen S-C, Senthil Kumar KJ, Yu K-N, Lee Chao P-D, Tsai S-Y, et al. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach. J Agric Food Chem. 2012;60(1):522\u201332. https:\/\/doi.org\/10.1021\/jf2040675.","journal-title":"J Agric Food Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02975-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T04:47:11Z","timestamp":1756442831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02975-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02975-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethics Committee of Birjand University of Medical Science (code of ethics: IR.BUMS.REC.1403.299).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors consent to the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"398"}}